Journals / Annals of Medical Research / 2020 / Cilt: 27 - Sayı: 1

The investigation of related factors for vancomycin resistant enterococcus colonization of inpatients at internal medicine service

Pages
259–265
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Patients colonized with VRE have been found to have higher GGT values and newresearch on this topic is considered to be needed

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Enterococci are located in the intestinal flora of animals and humans and have become a major cause of healthcare-associatedinfections over the years.
📊
Key Findings & Data:In this study, related factors were investigated for the isolation of vancomycin-resistant enterococci (VRE)from rectal swab specimens of patients admitted to the internal medicine service.Material and Methods: TRectal swab samples were obtained from 316 patients.
💡
Conclusion & Impact:Patients colonized with VRE have been found to have higher GGT values and newresearch on this topic is considered to be needed
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Enterococci are located in the intestinal flora of animals and humans and have become a major cause of healthcare-associatedinfections over the years. In this study, related factors were investigated for the isolation of vancomycin-resistant enterococci (VRE)from rectal swab specimens of patients admitted to the internal medicine service.Material and Methods: TRectal swab samples were obtained from 316 patients. VITEK-2 (bioMérieux, Marcy l’Etoile, France)automated system was used for identification of enterococci. Vancomycin susceptibility was studied by Kirby-Bauer disc diffusionmethod. Resistant strains were confirmed by vancomycin E-test (bioMerieux).Results: VRE was growth in 70 (22.2%) of 316 patients included in the study. According to the univariate analysis results whichcomparing patients who were colonized with VRE to the control group; These were found, the duration of hospitalization forVRE colonized patients was significantly longer, the usage of glycopeptide and metronidazole increased the VRE colonizationand VRE colonized patients were found to have more parenteral feeding. It was determined that hemoglobin, thyroxineand albumin values of patients colonized with VRE were lower. According to the logistic regression analysis, patients withVRE colonization had a higher rate of history in the intensive care unit and higher gamma glutamyl transferase value.Conclusion: It was determined that the hospitalization history in intensive care unit is a risk factor for VRE colonization and especiallyin patients transported from intensive care unit. Patients colonized with VRE have been found to have higher GGT values and newresearch on this topic is considered to be needed

🔖

Cite This Article

DAVARCI, İ., DAVARCI, P. Z., TÜRKMEN, F. M., ENGİN, D. Ö. (2022). The investigation of related factors for vancomycin resistant enterococcus colonization of inpatients at internal medicine service. Annals of Medical Research, Cilt: 27 - Sayı: 1, 259–265. https://ajindex.com/articles/446505

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Bayık SA, Mumcuoğlu İ, Kurşun Ş, et al. Clonal Analysis of Vancomycin-Resistant Enterocci Strains by repPCR Method. Turk Hij Tecr Biyol Derg 2016;73:1-8
  2. Mioljević V, Marković-Denić L, Vidović A, et al. Risk factors for vancomycin-resistant Enterococcus colonization in hematologic patients. Vojnosanit Pregl 2013;70:1109-16
  3. Amberpet R, Sistla S, Parija SC, et al. Screening for intestinal colonization with vancomycin resistant enterococci and associated risk factors among patients admitted to an adult intensive care unit of a large teaching hospital. J Clin Diagn Res 2016;10:DC06
  4. Vural T, Sekercioglu AO, Ogunc D, et al. Vancomycin resistant enterococcus casseliflavus strain. ANKEM Derg 1998;12:1
  5. Papadimitriou-Olivgeris M, Drougka E, Fligou F, et al. Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients. Infection 2014;42:1013-22
  6. Akturk H, Sutcu M, Somer A, et al. Results of FourYear Rectal Vancomycin-Resistant Enterococci Surveillance in a Pediatric Hematology-Oncology Ward: From Colonization to Infection. Turk J Haematol 2016;33:244-7
  7. Wayne PA. Performance Standards for antimicrobial susceptibility testing, 23rd informational supplement. Clinical and Laboratory Standards Institute 2013;100:23
  8. Karakeçili F, Dalyan Cilo B, Cikman A, et al. Molecular epidemiological analysis of vancomycin-resistant enterococci. Nobel Med 2017;13:22-8
  9. Hanci H, Uyanik M, Gültekin E, et al. In-vitro Activity of Daptomycin Against Enterococcus strains Isolated from Blood Cultures. J Turk Microbiol Soc 2015;44:91- 7
  10. Mete E, Kaleli I, Cevahir N, et al. Evaluation of virulence factors in enterococcus species. Mikrobiyol Bul 2017;51:101-14
  11. Ford CD, Lopansri BK, Haydoura S, et al. Frequency, risk factors, and outcomes of vancomycin-resistant Enterococcus colonization and infection in patients with newly diagnosed acute leukemia: different patterns in patients with acute myelogenous and acute lymphoblastic leukemia. Infect Control Hosp Epidemiol 2015;36:47-53
  12. Suntharam N, Lankford MG, Trick WE, et al. Risk factors for acquisition of vancomycin-resistant enterococci among hematology-oncology patients. Diagn Microbiol Infect Dis 2002;43:183-8
  13. Worth LJ, Thursky KA, Seymour JF, et al. Vancomycinresistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk. Eur J Haematol 2007;79:226-33
  14. Dubberke